EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of NTRK Fusions Detection Method in Esophageal Squamous Cell Carcinoma and Gastric Adenocarcinoma

Tomoyuki Momma, Motonobu Saito iD, Shotaro Nakajima, Katsuharu Saito, Erika Machida, Ken Miyabe, Yusuke Sato iD, Hiroyuki Hanayama, Hirokazu Okayama iD, Zenichiro Saze, Kosaku Mimura iD, Naoto Tsuchiya und 3 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms27010336 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Tomoyuki Momma und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan. Hauptthemen laut MEDLINE: Stomach Neoplasms, Esophageal Neoplasms, Adenocarcinoma, Esophageal Squamous Cell Carcinoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science (JSPS) KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurotrophic tyrosine receptor kinase (NTRK) fusions function as oncogenes and have been targeted by TRK inhibitors with excellent clinical outcomes. The international expert consensus recommends immunohistochemical (IHC) screening for TRK protein followed by next generation sequencing (NGS) to measure expression of NTRK fusions for tumors with low NTRK fusion expression. To confirm the clinical utility of this recommendation in esophageal and gastric cancers, total TRK protein expression was measured by IHC using anti-pan-TRK antibody in 254 esophageal squamous cell carcinoma (ESCC) and 401 gastric adenocarcinoma (GA) samples. Subsequently, DNA-based NGS and fluorescence in situ hybridization (FISH) were performed for tumors expressing TRK to measure NTRK fusion expression. Further, expression of NTRK fusions was evaluated in esophageal and gastric cancers using public databases. IHC staining revealed TRK was expressed in 10 out of 254 ESCC and 0 out of 401 GC cases. NGS and FISH analyses were performed for 10 TRK positive ESCC cases, identifying that none of these cases harbored NTRK fusions. In silico analyses further confirmed that NTRK fusions are rarely present in esophageal and gastric cancers. IHC screening for TRK protein is recommended to detect NTRK fusions, but this method may include many false-positives cases based on the sequencing analysis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsEsophageal NeoplasmsAdenocarcinomaEsophageal Squamous Cell CarcinomaReceptor, trkAOncogene Proteins, FusionHumansIn Situ Hybridization, FluorescenceHigh-Throughput Nucleotide SequencingImmunohistochemistryFemaleMaleBiomarkers, TumorMiddle AgedReceptor Protein-Tyrosine Kinases

Stichwörter der Autor:innen

NTRK fusionsesophageal squamous cell carcinomagastric adenocarcinoma

Substanzen

Receptor, trkAOncogene Proteins, FusionBiomarkers, TumorReceptor Protein-Tyrosine Kinases

Autor:innen und Institutionen

  • Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan.
  • Department of Cancer Genome Medicine, Fukushima Medical University Hospital, Fukushima 960-1295, Japan.
  • Department of Multidisciplinary Treatment of Cancer and Regional Medical Support, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan.
  • Division of Genome Biology, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
  • Department of Surgery, Saitama Medical Center, Jichi Medical University, Saitama 330-8503, Japan.
  • Department of Cellular and Organ Pathology, Graduate School of Medicine, Akita University, Akita 010-8543, Japan.

ORCID-Profile: Motonobu Saito, Yusuke Sato, Hirokazu Okayama, Kosaku Mimura, Akiteru Goto, Kouya Shiraishi

Förderung

  • Japan Society for the Promotion of Science (JSPS) KAKENHI

Zitieren

APA

Momma, T., Saito, M., Nakajima, S., Saito, K., Machida, E., Miyabe, K., Sato, Y., Hanayama, H., Okayama, H., Saze, Z., Mimura, K., Tsuchiya, N., Goto, A., Shiraishi, K., & Kono, K. (2025). Evaluation of NTRK Fusions Detection Method in Esophageal Squamous Cell Carcinoma and Gastric Adenocarcinoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27010336

Vancouver

Momma T, Saito M, Nakajima S, Saito K, Machida E, Miyabe K, et al. Evaluation of NTRK Fusions Detection Method in Esophageal Squamous Cell Carcinoma and Gastric Adenocarcinoma. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms27010336

BibTeX
@article{Momma2025,
  author = {Momma, Tomoyuki and Saito, Motonobu and Nakajima, Shotaro and Saito, Katsuharu and Machida, Erika and Miyabe, Ken and Sato, Yusuke and Hanayama, Hiroyuki and Okayama, Hirokazu and Saze, Zenichiro and Mimura, Kosaku and Tsuchiya, Naoto and Goto, Akiteru and Shiraishi, Kouya and Kono, Koji},
  title = {Evaluation of NTRK Fusions Detection Method in Esophageal Squamous Cell Carcinoma and Gastric Adenocarcinoma},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms27010336}
}
Kostenlos starten →